-
Start Preamble
Periodically, the Substance Abuse and Mental Health Services Administration (SAMHSA) will publish a summary of information collection requests under OMB review, in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these documents, call the SAMHSA Reports Clearance Officer on (240) 276-0361.
Project: Mandatory Guidelines for Federal Workplace Drug Testing Programs (OMB No. 0930-0158)—Revision
SAMHSA will request OMB approval for a revision of the Federal Drug Testing Custody and Control Form (CCF) for Federal agency and federally regulated drug testing programs which must comply with the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (UrMG) dated January 23, 2017 (82 FR 7920) and using Oral Fluid (OFMG) dated October 25, 2019, and OMB approval for information provided by test facilities (laboratories and Instrumented Initial Test Facilities, IITFs) for the National Laboratory Certification Program (NLCP).
The CCF is used by all Federal agencies and employers regulated by the Department of Transportation (DOT) and the Nuclear Regulatory Commission (NRC) to document the collection and chain of custody of urine specimens at the collection site, for HHS-certified test facilities to report results, and for Medical Review Officers (MROs) to document and report a verified result. SAMHSA allows the use of the CCF as a paper or electronic form.
The current OMB-approved CCF has an August 31, 2020 expiration date. SAMHSA has resubmitted the CCF with revisions to the form for OMB approval. During 60-day public comment 7 commenter's submitted comments on the proposed changes to the CCF. These commenters were comprised of individuals, organizations, and private sector companies. All comments were reviewed and taken into consideration in the preparation of the revised CCF. The issues and concerns raised in the public comments for the CCF are set out www.reginfo.gov/public/do/PRAMain.
These revisions are listed below:Start Printed Page 39205
Copies 1-5
Revised Step 1
1. Added “CDL State and No.” to donor identification types
2. Added “Collector Contact Info:” and “Other” line (e.g., email)
Revised Step 2
1. Put Urine and Oral Fluid checkboxes above Step 2 for collector to annotate
2. Expanded to 4 lines for collector entries:
—General entry for Split, Single, or None Provided (same as current)
—Entries specific to urine collection (moved “Collector reads urine temperature within 4 minutes” here; other entries same as current)
—Entries specific to oral fluid collection: Added “Split Type” with checkboxes for Serial, Concurrent, and Subdivided; “Each Device Within Expiration Date?” with checkboxes Yes or No; and Volume Indicator(s) Observed checkbox)
—Remarks (same as current)
Revised Step 3
1. Edited instruction to state “collector affixes seal(s) to bottle(s)/tube(s)”
Revised Step 4 (Collector Section)
1. Edited “Specimen Bottle(s) Released To” box to state “Specimen Bottle(s)/Tubes(s) Released To”
Copy 1 (Test Facility Copy)
Revised Step 4 (Accessioner Section)
1. Edited “Specimen Bottle(s) Released To” box to state “Specimen Bottle(s)/Tubes(s) Released To”
2. Added “Primary/Single Specimen Device Expiration Date” and “Split Specimen Device Expiration Date” fields for accessioner to annotate expiration dates of oral fluid collection devices
Revised Step 5a (Certification and Reporting Section)
1. Removed analyte names and checkboxes
2. Repositioned results and checkboxes: Moved REJECTED FOR TESTING, ADULTERATED, SUBSTITUTED and INVALID RESULT checkboxes; moved POSITIVE checkbox to be under DILUTE
3. Added line for certifying scientist to record positive analytes and concentrations, and added “Analyte(s) in ng/mL” instruction (aligned under “POSITIVE for:”)
Copy 2 (Medical Review Officer Copy)
Revised Step 5 (Donor Section)
1. Added line for donor email address
2. Edited donor certification statement to state “specimen bottle/tubes”
Revised Step 6 (MRO section—Primary Specimen)
1. Put Urine and Oral Fluid checkboxes above Step 6 for MRO to annotate
Bottom of Copies
Revised Copy 1
1. Edited label/seal at bottom of Copy 1 to allow for modification (e.g., perforations, label with transparent seal on one side, and separate label and seal)
Revised Copy 5
1. Removed Instructions for Completing the CCF from the back. SAMHSA will post instructions for completing the Federal CCF for urine and oral fluid on their website.
Based upon information from Federal agencies and from DOT concerning their regulated industries, the number of respondents has increased from 5.4 million to 6.7 million, which increases the total burden hours by 170,701.8-C;.
Laboratories and IITFs seeking HHS certification under the NLCP must complete and submit the NLCP application form. The NLCP application form has not been revised compared to the previous form.
Prior to an inspection, an HHS-certified laboratory or IITF is required to submit specific information regarding its procedures. Collecting this information prior to an inspection allows the inspectors to thoroughly review and understand the testing procedures before arriving for the onsite inspection. The NLCP information checklist has not been revised compared to the previous form.
The annual total burden estimates for the CCF, the NLCP application, the NLCP information checklist, and the NLCP recordkeeping requirements are shown in the following table.
Form/respondent Number of respondents Responses per respondent Total number of responses Burden per response (hours) Annual burden (hours) Custody and Control Form: 1 Donor 6,726,610 1 6,726,610 0.08 538,128.8 Collector 6,726,610 1 6,726,610 0.07 378,000 Laboratory 6,726,610 1 6,726,610 0.05 336,330 IITF 1 0 0 0.05 0 Medical Review Officer 6,726,610 1 6,726,610 0.05 270,000 NLCP Application Form: 2 Laboratory 5 5 5 3 15 IITF 0 0 0 3 0 Sections B and C—NLCP Inspection Checklist: Laboratory 29 1 29 1 29 IITF 0 0 0 1 0 Record Keeping: Laboratory 29 1 29 250 7,250 IITF 0 0 0 250 0 Total 6,726,673 26,906,503 1,529,753 Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting “Currently under 30-day Review—Open Start Printed Page 39206for Public Comments” or by using the search function.
Start SignatureCarlos Graham,
Social Science Analyst.
[FR Doc. 2020-13986 Filed 6-29-20; 8:45 am]
BILLING CODE 4162-20-P
Document Information
- Published:
- 06/30/2020
- Department:
- Substance Abuse and Mental Health Services Administration
- Entry Type:
- Notice
- Document Number:
- 2020-13986
- Pages:
- 39204-39206 (3 pages)
- PDF File:
- 2020-13986.pdf